With Risk of Reinfection, Is Covid-19 Here to Stay?

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

With Risk of Reinfection, Is Covid-19 Here to Stay? Publisher Pubmed

Jabbari P^{1, 2} ; Rezaei N^{1, 2, 3}

Show Affiliations

1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Dr. Qarib St., Keshavarz Blvd., Tehran, 14194, Iran
2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Disaster Medicine and Public Health Preparedness Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)

2. Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in Covid-19, Emergent Materials (2021)

3. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)

4. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)

5. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)

6. Role of Toll-Like Receptors in the Pathogenesis of Covid-19, Journal of Medical Virology (2021)

7. Death Due to Covid-19 in a Patient With Diabetes, Epilepsy, and Gout Comorbidities, Clinical Case Reports (2020)

8. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)

Experts (# of related papers)

Nima Rezaei (28)

Alireza Ghanadan (1)

Other Related Docs

9. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)

10. Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19), Reviews in the Neurosciences (2020)

11. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)

12. Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality, European Cytokine Network (2020)

13. Autoimmune Complications of Covid-19, Journal of Medical Virology (2022)

14. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)

15. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)

16. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)

17. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)

18. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the Covid-19 Pandemic, Advances in Experimental Medicine and Biology (2021)

19. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)

20. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)

21. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)

22. Primary Immunodeficiency Diseases in Covid-19 Pandemic: A Predisposing or Protective Factor?, American Journal of the Medical Sciences (2020)

23. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)

24. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)

25. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)

26. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)

27. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)

28. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)

Style	Citing Format
MLA	Jabbari P, Rezaei N. "With Risk of Reinfection, Is Covid-19 Here to Stay?." Disaster Medicine and Public Health Preparedness, vol. 14, no. 4, 2020, pp. E33-.
APA	Jabbari P, Rezaei N (2020). With Risk of Reinfection, Is Covid-19 Here to Stay?. Disaster Medicine and Public Health Preparedness, 14(4), E33-.
Chicago	Jabbari P, Rezaei N. "With Risk of Reinfection, Is Covid-19 Here to Stay?." Disaster Medicine and Public Health Preparedness 14, no. 4 (2020): E33-.
Harvard	Jabbari P, Rezaei N (2020) 'With Risk of Reinfection, Is Covid-19 Here to Stay?', Disaster Medicine and Public Health Preparedness, 14(4), pp. E33-.
Vancouver	Jabbari P, Rezaei N. With Risk of Reinfection, Is Covid-19 Here to Stay?. Disaster Medicine and Public Health Preparedness. 2020;14(4):E33-.
BibTex	@article{ author = {Jabbari P and Rezaei N}, title = {With Risk of Reinfection, Is Covid-19 Here to Stay?}, journal = {Disaster Medicine and Public Health Preparedness}, volume = {14}, number = {4}, pages = {E33-}, year = {2020} }
RIS	TY - JOUR AU - Jabbari P AU - Rezaei N TI - With Risk of Reinfection, Is Covid-19 Here to Stay? JO - Disaster Medicine and Public Health Preparedness VL - 14 IS - 4 SP - E33 EP - PY - 2020 ER -